2026 Scientific Sessions

Late Breaking Clinical Trials

Additional details coming soon.
Sirolimus Eluting Balloons for Patients with Acute Coronary Syndrome – Evidence from the SELUTION DeNovo Trial
Christian Spaulding1, Etienne Puymirat1, Andy Ladwiniec, MD2, Matthieu Godin3, Thomas Schmitz4, Axel Linke5, Simon Eccleshall6, Nick Curzen, Ph.D.7, Michael Dickinson8, Gioel Gabrio Secco9 and Clemens Steinwender10, (1)European Hospital Georges Pompidou, Paris, France, (2)University Hospitals of Leicester NHS Trust, Leicester, United Kingdom, (3)Clinique Saint-Hilaire, Rouen, France, (4)Department of Cardiology, Elisabeth Krankenhaus Essen, Essen, Germany, (5)Department of Internal Medicine and Cardiology Herat Center, University Clinic, University of Technology Dresden, Dresden, Germany, (6)Department of Cardiology, Norfolk and Norwich University Hospital & Honorary Associate Professor, University of East Anglia, Norwich Research Park, Norwich, United Kingdom, (7)University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom, (8)UMC Utrecht, Utrecht, Netherlands, (9)Ospedale Civile Santi Antonio e Biagio e Cesare Arrigo, Alessandria, Italy, (10)Kepler Universitätsklinikum GmbH, Linz, Austria
Discussion
Antonio Colombo, M.D., MSCAI, EMO GVM Centro Cuore Columbus, Milano, Milano, Italy
AltaValve Early Feasibility Study: One-Year Outcomes with Atrial Fixation Transcatheter Mitral Valve Replacement
Ninios Vlasis, M.D., Interbalkan Medical Center, Thessaloniki, Thessaloniki, Greece, Krzysztof Wróbel, M.D., Ph.D., Lazarski University, Warsaw, Warsaw, Masovian Voivodeship, Poland, Marek Grygier, M.D., Chair and 1st Department of Cardiology, Poznan University of Medical Sciences, Pozan, Wielkopolskie Voivodeship, Poland, Paul Sorajja, M.D., FSCAI, Banner Health, Phoenix, AZ, Naeem K. Tahirkheli, M.D., Oklahoma Cardiovascular Associates, Edmond, OK, Philippe Genereux MD, M.D., Atlantic Health System, Morristown, NJ, Michael J. Rinaldi, M.D., FSCAI, Sanger Heart & Vascular Institute, Charlotte, NC, Michael J. Reardon, MD, Houston Methodist Hospital, Houston, TX, Michael O Zembala, M.D., Department of Cardiac Surgery, Heart and Lung Transplantation and Mechanical Circulatory Support, Silesian Center For Heart Diseases, Zabrze, Silesian Voivodeship, Poland, Hiram G Bezerra, M.D., Ph.D., Tampa General Hospital, tAMPA, FL, Thomas E. Waggoner, D.O., Pima Heart & Vascular - Westside, Tucson, AZ, Konstantinos Voudris, M.D., Ph.D., FSCAI, Minneapolis Heart Institute - Abbott Northwestern Hospital, Minneapolis , MN, Ron Waksman, M.D., MedStar Washington Hospital Center, Washington, DC and Vinayak Bapat, M.D., Valve Science Center, Minneapolis Heart Institute Foundation, Minneapolis, MN
Discussion
David J. Cohen, M.D., FSCAI, St. Francis Hospital, New York, NY
PROMISE III: 6-Month Clinical and Quality of Life Outcomes in CLTI Patients Treated with Transcatheter Arterialization of the Deep Veins
Mehdi H. Shishehbor, D.O., MPH, PhD, FSCAI, University Hospitals Harrington Heart & Vascular Institute, Cleveland, OH and Daniel G. Clair, MD, Vanderbilt University Medical Center, Nashville, TN
Discussion
Sahil A. Parikh, MD, FSCAI, NewYork-Presbyterian Columbia University Irving Medical Center, New York, NY
Can Escalation Reduce Acute myocardial infarction Mortality In Cardiogenic Shock (CERAMICS)
Babar B Basir, DO, FSCAI, Henry Ford Health System, Detroit, MI, Mohan Brar, MD, St. Elizabeth Physicians, Cedar Rapids, IA, Brian C Kolski, MD, OC Heart Institute, Orange, CA, Joshua W. Todd, M.D., FSCAI, Knoxville Heart Group, Knoxville, TN, Allison G. Dupont, M.D., FSCAI, Northside Hospital Heart Institute, Lawrenceville, GA, Amir Kaki, M.D., FSCAI, Henry Ford St. John Hospital, Birmingham, MI, Kirit Patel, MD, Trinity Health Oakland, Pontiac, MI, India, Dr. Aditya Mehra, M.D., FSCAI, Hackensack Meridian Ocean University Medical Center, Brick, NJ, David H Wohns, M.D., FSCAI, Corewell Health/Michigan State, Grand Rapids, MI, David M. Lasorda, D.O., FSCAI, Allegheny Health Network , Pittsburgh, PA, Nainesh C. Patel, M.D., FSCAI, Lehigh Valley Health Network, Allentown, PA, Dr. Aditya Bharadwaj, M.B.B.S., FSCAI, University of Miami Miller School of Medicine, Miami, FL, Ann Gage, M.D., TriStar Centennial Medical Center, Nashville, TN, Nandish K. Thukral, M.D., FSCAI, Methodist Cardiology Clinic of San Antonio, San Antonio, TX, Ali Nsair, MD, Ronald Reagan UCLA Medical Center, Los Angeles, CA, Santiago Garcia, MD, FSCAI, The Christ Hospital Health Network, Cincinnati, OH, Nima Aghili, M.D., Colorado Heart and Vascular, Lakewood, CO, Ayaz Rahman, MD, Parkwest, Knoxsville, TN, Angela Taylor, M.D., The University of Virginia, Charlottesville, VA, Ramesh Mazhari, M.D., FSCAI, George Washington University, Washington, DC and William W. O'Neill, MD, MSCAI, Henry Ford Health System, Orchard Lake, MI
Trial Update: Clinically Important Subgroups from STEMI D2U
Norman Mangner, Heart Center Dresden, University Hospital, Dresden, Germany
Discussion
Kate Kearney, M.D., FSCAI, The University of Washington, Seattle, WA
See more of: Featured Sessions